Biodesix Inc. (BDSX) Tops Q2 EPS by 7c

Biodesix Inc. (NASDAQ: BDSX) reported Q2 EPS of ($0.40), $0.07 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $7.3 million versus the consensus estimate of $8.83 million.

GUIDANCE:

Biodesix Inc. sees FY2022 revenue of $37.5-39.5 million, versus the consensus of $38.4 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
• Azitra, Inc. (AZTR) Tops Q2 EPS by 54c